News Digging > Science > Scleroderma treatment could leap forward with FT011
Scleroderma treatment could leap forward with FT011
Scleroderma treatment could leap forward with FT011,The story of the scleroderma drug candidate FT011 is one of "tenacity and persistence," said Darren Kelly, CEO of Certa Therapeutics.

Scleroderma treatment could leap forward with FT011

The story of the scleroderma drug candidate FT011 is one of "tenacity and persistence," said Darren Kelly, CEO of Certa Therapeutics.